{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.875","upperLimit":"1.00","value":"0.913"}]}],"title":"5-FU infusion"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.789","upperLimit":"0.968","value":"0.850"}]}],"title":"Oxaliplatin"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.455","upperLimit":"0.917","value":"0.643"}]}],"title":"5-FU bolus"}],"denoms":[{"counts":[{"groupId":"OG000","value":"45"}],"units":"Participants"}],"description":"Relative dose intensity (RDI) of chemotherapy. RDI is defined as (planned cumulative dose/cumulative administered dose)\\*(actual duration/planned duration). RDI will be calculated separately for each component of the FOLFOX regimen (5-FU bolus, 5-FU infusion, oxaliplatin).","dispersionType":"Inter-Quartile Range","groups":[{"description":"Participants completing six cycles of FOLFOX (evaluable population for relative dose intensity)","id":"OG000","title":"Participants Completing Six Cycles of FOLFOX"}],"paramType":"MEAN","reportingStatus":"POSTED","timeFrame":"Through day 1 of cycle 6 of FOLFOX chemotherapy (cycle length is 14 days)","title":"Relative Dose Intensity of Chemotherapy","type":"SECONDARY","unitOfMeasure":"Percentage"}